Report Detail

Pharma & Healthcare Global Pet Calming Aid Market Research Report 2022

  • RnM4462731
  • |
  • 06 July, 2022
  • |
  • Global
  • |
  • 112 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Industry Insights
Due to the COVID-19 pandemic, the global Pet Calming Aid market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Pet Calming Aid market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Pet Calming Aid landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Tablet accounting for % of the Pet Calming Aid global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Household segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Pet Calming Aid include The Anxious Pet, This Dog's Life, NaturVet, King Kanine, Dr. Harvey’s, PetHonesty, Rescue Remedy, Zesty Paws and Maxxidog, etc. In terms of revenue, the global 3 largest players have a % market share of Pet Calming Aid in 2021.

This report focuses on Pet Calming Aid volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Pet Calming Aid market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Pet Calming Aid market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Tablet

Powder

Liquid

Segment by Application

Household

Pet Shop

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

The Anxious Pet

This Dog's Life

NaturVet

King Kanine

Dr. Harvey’s

PetHonesty

Rescue Remedy

Zesty Paws

Maxxidog

Heavenly Hounds

ElleVet Sciences

Wild One

FOMO Bones

Ark Naturals

Purina

Kradle

Thunder

Finn

Pet Remedy

VetIQ

Zylkene

Adaptil

Primo Pup

Penelope's Bloom

Extract Labs

Koi CBD

Reggie

Zatural

Frequently Asked Questions

Which product segment grabbed the largest share in the Pet Calming Aid market?

How is the competitive scenario of the Pet Calming Aid market?

Which are the key factors aiding the Pet Calming Aid market growth?

Which are the prominent players in the Pet Calming Aid market?

Which region holds the maximum share in the Pet Calming Aid market?

What will be the CAGR of the Pet Calming Aid market during the forecast period?

Which application segment emerged as the leading segment in the Pet Calming Aid market?

What key trends are likely to emerge in the Pet Calming Aid market in the coming years?

What will be the Pet Calming Aid market size by 2028?

Which company held the largest share in the Pet Calming Aid market?


1 Pet Calming Aid Market Overview

  • 1.1 Product Overview and Scope of Pet Calming Aid
  • 1.2 Pet Calming Aid Segment by Type
  • 1.2.1 Global Pet Calming Aid Sales Growth Rate Comparison by Type (2022-2028)
  • 1.2.2 Tablet
  • 1.2.3 Powder
  • 1.2.4 Liquid
  • 1.3 Pet Calming Aid Segment by Application
  • 1.3.1 Global Pet Calming Aid Sales Comparison by Application: (2022-2028)
  • 1.3.2 Household
  • 1.3.3 Pet Shop
  • 1.3.4 Others
  • 1.4 Global Pet Calming Aid Market Size Estimates and Forecasts
  • 1.4.1 Global Pet Calming Aid Revenue 2017-2028
  • 1.4.2 Global Pet Calming Aid Sales 2017-2028
  • 1.4.3 Pet Calming Aid Market Size by Region: 2017 Versus 2021 Versus 2028
  • 2 Pet Calming Aid Market Competition by Manufacturers

    • 2.1 Global Pet Calming Aid Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Pet Calming Aid Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Pet Calming Aid Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Pet Calming Aid Manufacturing Sites, Area Served, Product Type
    • 2.5 Pet Calming Aid Market Competitive Situation and Trends
    • 2.5.1 Pet Calming Aid Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Pet Calming Aid Players Market Share by Revenue
  • 2.5.3 Global Pet Calming Aid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 3 Pet Calming Aid Retrospective Market Scenario by Region

    • 3.1 Global Pet Calming Aid Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Pet Calming Aid Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Pet Calming Aid Market Facts & Figures by Country
    • 3.3.1 North America Pet Calming Aid Sales by Country
  • 3.3.2 North America Pet Calming Aid Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
  • 3.4 Europe Pet Calming Aid Market Facts & Figures by Country
  • 3.4.1 Europe Pet Calming Aid Sales by Country
  • 3.4.2 Europe Pet Calming Aid Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
  • 3.5 Asia Pacific Pet Calming Aid Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Pet Calming Aid Sales by Region
  • 3.5.2 Asia Pacific Pet Calming Aid Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.6 Latin America Pet Calming Aid Market Facts & Figures by Country
  • 3.6.1 Latin America Pet Calming Aid Sales by Country
  • 3.6.2 Latin America Pet Calming Aid Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
  • 3.7 Middle East and Africa Pet Calming Aid Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Pet Calming Aid Sales by Country
  • 3.7.2 Middle East and Africa Pet Calming Aid Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE
  • 4 Global Pet Calming Aid Historic Market Analysis by Type

    • 4.1 Global Pet Calming Aid Sales Market Share by Type (2017-2022)
    • 4.2 Global Pet Calming Aid Revenue Market Share by Type (2017-2022)
    • 4.3 Global Pet Calming Aid Price by Type (2017-2022)

    5 Global Pet Calming Aid Historic Market Analysis by Application

    • 5.1 Global Pet Calming Aid Sales Market Share by Application (2017-2022)
    • 5.2 Global Pet Calming Aid Revenue Market Share by Application (2017-2022)
    • 5.3 Global Pet Calming Aid Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 The Anxious Pet
    • 6.1.1 The Anxious Pet Corporation Information
  • 6.1.2 The Anxious Pet Description and Business Overview
  • 6.1.3 The Anxious Pet Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 The Anxious Pet Pet Calming Aid Product Portfolio
  • 6.1.5 The Anxious Pet Recent Developments/Updates
  • 6.2 This Dog's Life
  • 6.2.1 This Dog's Life Corporation Information
  • 6.2.2 This Dog's Life Description and Business Overview
  • 6.2.3 This Dog's Life Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 This Dog's Life Pet Calming Aid Product Portfolio
  • 6.2.5 This Dog's Life Recent Developments/Updates
  • 6.3 NaturVet
  • 6.3.1 NaturVet Corporation Information
  • 6.3.2 NaturVet Description and Business Overview
  • 6.3.3 NaturVet Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 NaturVet Pet Calming Aid Product Portfolio
  • 6.3.5 NaturVet Recent Developments/Updates
  • 6.4 King Kanine
  • 6.4.1 King Kanine Corporation Information
  • 6.4.2 King Kanine Description and Business Overview
  • 6.4.3 King Kanine Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 King Kanine Pet Calming Aid Product Portfolio
  • 6.4.5 King Kanine Recent Developments/Updates
  • 6.5 Dr. Harvey’s
  • 6.5.1 Dr. Harvey’s Corporation Information
  • 6.5.2 Dr. Harvey’s Description and Business Overview
  • 6.5.3 Dr. Harvey’s Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 Dr. Harvey’s Pet Calming Aid Product Portfolio
  • 6.5.5 Dr. Harvey’s Recent Developments/Updates
  • 6.6 PetHonesty
  • 6.6.1 PetHonesty Corporation Information
  • 6.6.2 PetHonesty Description and Business Overview
  • 6.6.3 PetHonesty Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 PetHonesty Pet Calming Aid Product Portfolio
  • 6.6.5 PetHonesty Recent Developments/Updates
  • 6.7 Rescue Remedy
  • 6.6.1 Rescue Remedy Corporation Information
  • 6.6.2 Rescue Remedy Description and Business Overview
  • 6.6.3 Rescue Remedy Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Rescue Remedy Pet Calming Aid Product Portfolio
  • 6.7.5 Rescue Remedy Recent Developments/Updates
  • 6.8 Zesty Paws
  • 6.8.1 Zesty Paws Corporation Information
  • 6.8.2 Zesty Paws Description and Business Overview
  • 6.8.3 Zesty Paws Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 Zesty Paws Pet Calming Aid Product Portfolio
  • 6.8.5 Zesty Paws Recent Developments/Updates
  • 6.9 Maxxidog
  • 6.9.1 Maxxidog Corporation Information
  • 6.9.2 Maxxidog Description and Business Overview
  • 6.9.3 Maxxidog Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.9.4 Maxxidog Pet Calming Aid Product Portfolio
  • 6.9.5 Maxxidog Recent Developments/Updates
  • 6.10 Heavenly Hounds
  • 6.10.1 Heavenly Hounds Corporation Information
  • 6.10.2 Heavenly Hounds Description and Business Overview
  • 6.10.3 Heavenly Hounds Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.10.4 Heavenly Hounds Pet Calming Aid Product Portfolio
  • 6.10.5 Heavenly Hounds Recent Developments/Updates
  • 6.11 ElleVet Sciences
  • 6.11.1 ElleVet Sciences Corporation Information
  • 6.11.2 ElleVet Sciences Pet Calming Aid Description and Business Overview
  • 6.11.3 ElleVet Sciences Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.11.4 ElleVet Sciences Pet Calming Aid Product Portfolio
  • 6.11.5 ElleVet Sciences Recent Developments/Updates
  • 6.12 Wild One
  • 6.12.1 Wild One Corporation Information
  • 6.12.2 Wild One Pet Calming Aid Description and Business Overview
  • 6.12.3 Wild One Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.12.4 Wild One Pet Calming Aid Product Portfolio
  • 6.12.5 Wild One Recent Developments/Updates
  • 6.13 FOMO Bones
  • 6.13.1 FOMO Bones Corporation Information
  • 6.13.2 FOMO Bones Pet Calming Aid Description and Business Overview
  • 6.13.3 FOMO Bones Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.13.4 FOMO Bones Pet Calming Aid Product Portfolio
  • 6.13.5 FOMO Bones Recent Developments/Updates
  • 6.14 Ark Naturals
  • 6.14.1 Ark Naturals Corporation Information
  • 6.14.2 Ark Naturals Pet Calming Aid Description and Business Overview
  • 6.14.3 Ark Naturals Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.14.4 Ark Naturals Pet Calming Aid Product Portfolio
  • 6.14.5 Ark Naturals Recent Developments/Updates
  • 6.15 Purina
  • 6.15.1 Purina Corporation Information
  • 6.15.2 Purina Pet Calming Aid Description and Business Overview
  • 6.15.3 Purina Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.15.4 Purina Pet Calming Aid Product Portfolio
  • 6.15.5 Purina Recent Developments/Updates
  • 6.16 Kradle
  • 6.16.1 Kradle Corporation Information
  • 6.16.2 Kradle Pet Calming Aid Description and Business Overview
  • 6.16.3 Kradle Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.16.4 Kradle Pet Calming Aid Product Portfolio
  • 6.16.5 Kradle Recent Developments/Updates
  • 6.17 Thunder
  • 6.17.1 Thunder Corporation Information
  • 6.17.2 Thunder Pet Calming Aid Description and Business Overview
  • 6.17.3 Thunder Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.17.4 Thunder Pet Calming Aid Product Portfolio
  • 6.17.5 Thunder Recent Developments/Updates
  • 6.18 Finn
  • 6.18.1 Finn Corporation Information
  • 6.18.2 Finn Pet Calming Aid Description and Business Overview
  • 6.18.3 Finn Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.18.4 Finn Pet Calming Aid Product Portfolio
  • 6.18.5 Finn Recent Developments/Updates
  • 6.19 Pet Remedy
  • 6.19.1 Pet Remedy Corporation Information
  • 6.19.2 Pet Remedy Pet Calming Aid Description and Business Overview
  • 6.19.3 Pet Remedy Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.19.4 Pet Remedy Pet Calming Aid Product Portfolio
  • 6.19.5 Pet Remedy Recent Developments/Updates
  • 6.20 VetIQ
  • 6.20.1 VetIQ Corporation Information
  • 6.20.2 VetIQ Pet Calming Aid Description and Business Overview
  • 6.20.3 VetIQ Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.20.4 VetIQ Pet Calming Aid Product Portfolio
  • 6.20.5 VetIQ Recent Developments/Updates
  • 6.21 Zylkene
  • 6.21.1 Zylkene Corporation Information
  • 6.21.2 Zylkene Pet Calming Aid Description and Business Overview
  • 6.21.3 Zylkene Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.21.4 Zylkene Pet Calming Aid Product Portfolio
  • 6.21.5 Zylkene Recent Developments/Updates
  • 6.22 Adaptil
  • 6.22.1 Adaptil Corporation Information
  • 6.22.2 Adaptil Pet Calming Aid Description and Business Overview
  • 6.22.3 Adaptil Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.22.4 Adaptil Pet Calming Aid Product Portfolio
  • 6.22.5 Adaptil Recent Developments/Updates
  • 6.23 Primo Pup
  • 6.23.1 Primo Pup Corporation Information
  • 6.23.2 Primo Pup Pet Calming Aid Description and Business Overview
  • 6.23.3 Primo Pup Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.23.4 Primo Pup Pet Calming Aid Product Portfolio
  • 6.23.5 Primo Pup Recent Developments/Updates
  • 6.24 Penelope's Bloom
  • 6.24.1 Penelope's Bloom Corporation Information
  • 6.24.2 Penelope's Bloom Pet Calming Aid Description and Business Overview
  • 6.24.3 Penelope's Bloom Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.24.4 Penelope's Bloom Pet Calming Aid Product Portfolio
  • 6.24.5 Penelope's Bloom Recent Developments/Updates
  • 6.25 Extract Labs
  • 6.25.1 Extract Labs Corporation Information
  • 6.25.2 Extract Labs Pet Calming Aid Description and Business Overview
  • 6.25.3 Extract Labs Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.25.4 Extract Labs Pet Calming Aid Product Portfolio
  • 6.25.5 Extract Labs Recent Developments/Updates
  • 6.26 Koi CBD
  • 6.26.1 Koi CBD Corporation Information
  • 6.26.2 Koi CBD Pet Calming Aid Description and Business Overview
  • 6.26.3 Koi CBD Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.26.4 Koi CBD Pet Calming Aid Product Portfolio
  • 6.26.5 Koi CBD Recent Developments/Updates
  • 6.27 Reggie
  • 6.27.1 Reggie Corporation Information
  • 6.27.2 Reggie Pet Calming Aid Description and Business Overview
  • 6.27.3 Reggie Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.27.4 Reggie Pet Calming Aid Product Portfolio
  • 6.27.5 Reggie Recent Developments/Updates
  • 6.28 Zatural
  • 6.28.1 Zatural Corporation Information
  • 6.28.2 Zatural Pet Calming Aid Description and Business Overview
  • 6.28.3 Zatural Pet Calming Aid Sales, Revenue and Gross Margin (2017-2022)
  • 6.28.4 Zatural Pet Calming Aid Product Portfolio
  • 6.28.5 Zatural Recent Developments/Updates
  • 7 Pet Calming Aid Manufacturing Cost Analysis

    • 7.1 Pet Calming Aid Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Pet Calming Aid
  • 7.4 Pet Calming Aid Industrial Chain Analysis
  • 8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Pet Calming Aid Distributors List
    • 8.3 Pet Calming Aid Customers

    9 Pet Calming Aid Market Dynamics

    • 9.1 Pet Calming Aid Industry Trends
    • 9.2 Pet Calming Aid Market Drivers
    • 9.3 Pet Calming Aid Market Challenges
    • 9.4 Pet Calming Aid Market Restraints

    10 Global Market Forecast

    • 10.1 Pet Calming Aid Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Pet Calming Aid by Type (2023-2028)
  • 10.1.2 Global Forecasted Revenue of Pet Calming Aid by Type (2023-2028)
  • 10.2 Pet Calming Aid Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Pet Calming Aid by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of Pet Calming Aid by Application (2023-2028)
  • 10.3 Pet Calming Aid Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Pet Calming Aid by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of Pet Calming Aid by Region (2023-2028)
  • 11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
    • 12.3 Author List
    • Summary:
      Get latest Market Research Reports on Pet Calming Aid. Industry analysis & Market Report on Pet Calming Aid is a syndicated market report, published as Global Pet Calming Aid Market Research Report 2022. It is complete Research Study and Industry Analysis of Pet Calming Aid market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,305.50
      4,611.00
      2,682.50
      5,365.00
      453,618.00
      907,236.00
      242,237.00
      484,474.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report